Preclinical evaluation of IQS019, a novel BCR kinase inhibitor, in in vitro and in vivo models of non-Hodgkin lymphoma

Patricia Balsas; Jocabed Roldan; Laura Jimenez; Vanina Rodriguez; Raimon Puig de la Bellacasa; Jordi Teixido; Alba Matas-Cespedes; Alexandra Moros; Antonio Martinez; Elias Campo; Jose I. Borrell; Patricia Perez-Galan; Dolors Colomer; Gael Roue

doi:10.1158/1538-7445.AM2015-5317

Preclinical evaluation of IQS019, a novel BCR kinase inhibitor, in in vitro and in vivo models of non-Hodgkin lymphoma

Patricia Balsas, Jocabed Roldan, Laura Jimenez, Vanina Rodriguez, Raimon Puig de la Bellacasa, Jordi Teixido, Alba Matas-Cespedes, Alexandra Moros, Antonio Martinez, Elias Campo, Jose I. Borrell, Patricia Perez-Galan, Dolors Colomer, Gael Roue

Research output: Indexed journal article › Meeting Abstract › peer-review

Original language	English
Number of pages	3
Journal	Cancer Research
Volume	75
Issue number	15 Supplement
DOIs	https://doi.org/10.1158/1538-7445.AM2015-5317
Publication status	Published - 1 Aug 2015

Access to Document

10.1158/1538-7445.AM2015-5317

Cite this

Balsas, P., Roldan, J., Jimenez, L., Rodriguez, V., Puig de la Bellacasa, R., Teixido, J., Matas-Cespedes, A., Moros, A., Martinez, A., Campo, E., Borrell, J. I., Perez-Galan, P., Colomer, D., & Roue, G. (2015). Preclinical evaluation of IQS019, a novel BCR kinase inhibitor, in in vitro and in vivo models of non-Hodgkin lymphoma. Cancer Research, 75(15 Supplement). https://doi.org/10.1158/1538-7445.AM2015-5317

@article{0161cb48d4644f22b2f2656f247e3621,

title = "Preclinical evaluation of IQS019, a novel BCR kinase inhibitor, in in vitro and in vivo models of non-Hodgkin lymphoma",

author = "Patricia Balsas and Jocabed Roldan and Laura Jimenez and Vanina Rodriguez and {Puig de la Bellacasa}, Raimon and Jordi Teixido and Alba Matas-Cespedes and Alexandra Moros and Antonio Martinez and Elias Campo and Borrell, {Jose I.} and Patricia Perez-Galan and Dolors Colomer and Gael Roue",

year = "2015",

month = aug,

day = "1",

doi = "10.1158/1538-7445.AM2015-5317",

language = "English",

volume = "75",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "15 Supplement",

}

Balsas, P, Roldan, J, Jimenez, L, Rodriguez, V, Puig de la Bellacasa, R , Teixido, J, Matas-Cespedes, A, Moros, A, Martinez, A, Campo, E, Borrell, JI, Perez-Galan, P, Colomer, D & Roue, G 2015, 'Preclinical evaluation of IQS019, a novel BCR kinase inhibitor, in in vitro and in vivo models of non-Hodgkin lymphoma', Cancer Research, vol. 75, no. 15 Supplement. https://doi.org/10.1158/1538-7445.AM2015-5317

TY - JOUR

T1 - Preclinical evaluation of IQS019, a novel BCR kinase inhibitor, in in vitro and in vivo models of non-Hodgkin lymphoma

AU - Balsas, Patricia

AU - Roldan, Jocabed

AU - Jimenez, Laura

AU - Rodriguez, Vanina

AU - Puig de la Bellacasa, Raimon

AU - Teixido, Jordi

AU - Matas-Cespedes, Alba

AU - Moros, Alexandra

AU - Martinez, Antonio

AU - Campo, Elias

AU - Borrell, Jose I.

AU - Perez-Galan, Patricia

AU - Colomer, Dolors

AU - Roue, Gael

PY - 2015/8/1

Y1 - 2015/8/1

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_univeritat_ramon_llull&SrcAuth=WosAPI&KeyUT=WOS:000371597105454&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1158/1538-7445.AM2015-5317

DO - 10.1158/1538-7445.AM2015-5317

M3 - Meeting Abstract

SN - 0008-5472

VL - 75

JO - Cancer Research

JF - Cancer Research

IS - 15 Supplement

ER -

Preclinical evaluation of IQS019, a novel BCR kinase inhibitor, in in vitro and in vivo models of non-Hodgkin lymphoma

Access to Document

Other files and links

Cite this